An official website of the United States government Here’s how you know

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

In this section: Center for Drug Evaluation and Research (CDER)

Division of Oncology 1 (DO1)

The Division of Oncology 1 (DO1) regulates Investigational New Drug Applications (INDs), New Drug Applications (NDAs) and Biologic Licensing Applications (BLAs) for breast, gynecologic, and genitourinary cancers, as well as supportive care (non-hematologic) products.

Mailing Address

Food and Drug Administration
Center for Drug Evaluation and Research
Division of Oncology 1 (DO1)
5901-B Ammendale Road
Beltsville, MD 20705-1266

Phone: (301) 796-2330
Fax: (301) 796-9845

Resources For You

Top